Search results for "Squamous cell"

showing 10 items of 469 documents

Test system for trifunctional antibodies in 3D MCTS culture.

2009

The aim of the present study was to assess the feasibility of a 3D tumor cell culture model, that is, multicellular tumor spheroids (MCTSs) as an adequate model for micrometastases and therefore as a pharmacological model for efficacy testing of trifunctional therapeutic antibodies. Unlike conventional monolayer cultures, spheroids allow researchers to study parameters, such as 3D cell shape, 3D cell arrangement and microenvironment, and penetration efficiency of defense cells that may largely influence the efficacy of antibody treatment in vivo. The authors established a long-term coculture of human MCTSs with peripheral blood mononuclear cells (PBMCs) to test the anticancer effect of the …

Culture modelAntibodies NeoplasmCell SurvivalCellCatumaxomabCell Culture TechniquesApoptosisEfficiencyBiochemistryPeripheral blood mononuclear cellCancer VaccinesAnalytical ChemistryIn vivoSpheroids CellularAntibodies BispecificmedicineTumor Cells CulturedHumansCell ProliferationbiologySpheroidTrifunctional antibodymedicine.anatomical_structureHead and Neck NeoplasmsImmunologybiology.proteinCancer researchCarcinoma Squamous CellMolecular MedicineImmunotherapyAntibodyBiotechnologymedicine.drugJournal of biomolecular screening
researchProduct

The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review)

2013

Oral Squamous Cell Carcinoma (OSCC) is biologically characterized by the accumulation of multiple genetic and molecular alterations that end up clinically characterized as a malignant neoplasm through a phenomenon known as multistep. The members of the Cip/Kip family, specifically p21 Waf 1/CIP1 , are responsible for cell cycle control, blocking the transition from phase G1 to phase S. We made a search of articles of peer-reviewed Journals in PubMed/ Medline, crossing the keywords. The goal of this paper is to determine the relationship between p21 Waf 1/ CIP1 expression and several clinical and pathological aspects of OSCC, their relationship with p53 and HPV, as well as genetic alteration…

Cyclin-Dependent Kinase Inhibitor p21Pathologymedicine.medical_specialtyRegulatorOdontologíaCarcinomamedicineBasal cellP21waf1 cip1General DentistryPathologicalMouth neoplasmOral Medicine and PathologyTransition (genetics)business.industryCell CycleReview-ArticleCell cyclemedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludstomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASCancer researchCarcinoma Squamous CellSurgeryMouth Neoplasmsbusiness
researchProduct

Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker

2007

Survivin functions as an apoptosis inhibitor and a regulator of cell division in many tumours. The intracellular localization of survivin in tumours has been suggested as a prognostic marker. However, current reports are inconsistent and the underlying molecular mechanisms are not understood. The present study has examined the localization and prognostic value of nuclear and cytoplasmic survivin in the pre-therapeutic biopsies from 71 oral and oropharyngeal squamous carcinoma (OSCC) patients. Statistical analysis indicated that preferential nuclear versus cytoplasmic survivin correlated with favourable versus unfavourable disease outcome. Uni- and multi-variate analysis showed that in contr…

CytoplasmProgrammed cell deathPathologymedicine.medical_specialtySurvivinReceptors Cytoplasmic and NuclearApoptosisKaplan-Meier EstimateCysteine Proteinase InhibitorsKaryopherinsInhibitor of Apoptosis ProteinsPathology and Forensic MedicineCell Line TumorSurvivinBiomarkers TumorCarcinomaHumansMedicineNuclear export signalneoplasmsCell NucleusNuclear Export SignalsPredictive markerbusiness.industryCell cyclePrognosismedicine.diseaseImmunohistochemistryNeoplasm ProteinsSquamous carcinomaOropharyngeal NeoplasmsHead and Neck NeoplasmsApoptosisCarcinoma Squamous CellCancer researchMouth NeoplasmsbusinessMicrotubule-Associated ProteinsThe Journal of Pathology
researchProduct

A bioluminescence technique for quantitative and structure-associated imaging of pyruvate

2006

A novel bioluminescence assay has been developed for measuring pyruvate within sections of snap-frozen tissue in a quantitative manner as well as with a spatial resolution on a microscopical level. The assay was verified via HPLC and two independent photometric tests. The novel assay makes it possible to determine pyruvate concentrations in cryosections in the range of 0-5.0 micromol/g tissue (dry weight). Based on the analysis of samples of given pyruvate concentrations, the assay exhibits a recovery with a deviationor =15%. The minimal detectable amount was 0.02 pmol based on a 20 microm thick tissue section with an area of 1 cm(2). Combination of the already established imaging biolumine…

Diagnostic ImagingMetaboliteBiologyHigh-performance liquid chromatographyPathology and Forensic Medicinechemistry.chemical_compoundMuscular DiseasesPyruvic AcidBiomarkers TumorFrozen SectionsHumansBioluminescenceGlycolysisLactic AcidNeoplasms Squamous CellRadiosensitivityMolecular BiologyChromatography High Pressure LiquidMusclesCell BiologyLactic acidLuminescent ProteinschemistryBiochemistryHead and Neck NeoplasmsLuminescent MeasurementsCancer cellBiological AssayGlycolysisOxidation-ReductionQuantitative analysis (chemistry)Laboratory Investigation
researchProduct

5-Fluorouracil Buccal Tablets for Locoregional Chemotherapy of Oral Squamous Cell Carcinoma: Formulation, Drug Release and Histological Effects on Re…

2010

5-Fluorouracil (5-FU) is currently used for treatment of oral squamous cell carcinoma (OSCC). 5-FU is given by i.v. although the systemic administration is associated with severe toxic effects and no topical formulations of 5-FU for buccal drug delivery have been reported. In this study we would report the development of buccal tablets suitable for direct application of low-doses of 5-FU on cancer lesions. The topical administration could be effective on tumor area while systemic undesired side effects are avoided. Preliminarily, the limited tendency of 5-FU to cross the buccal tissue was established using reconstituted human oral epithelium (RHOE, in vitro) and porcine buccal mucosa (ex vi…

DrugAntimetabolites AntineoplasticPathologymedicine.medical_specialtySwineChemistry PharmaceuticalDrug Compounding5-Fluorouracilmedia_common.quotation_subjectPharmaceutical ScienceApoptosisSettore MED/08 - Anatomia PatologicaLocoregional drug deliveryOral Squamous Cell CarcinomaPermeabilityTissue Culture TechniquesDrug Delivery SystemsSettore MED/28 - Malattie OdontostomatologicheCarcinomaAnimalsHumansMedicinemedia_commonbusiness.industryMouth MucosaAdministration BuccalCancerBuccal administrationmedicine.diseaseReconstituted Human Oral Epitheliumstomatognathic diseasesSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoFluorouracilDrug deliveryCarcinoma Squamous CellSystemic administrationMouth NeoplasmsFluorouracilPorcine buccal mucosaBuccal tabletsbusinessEx vivoTabletsmedicine.drugCurrent Drug Delivery
researchProduct

Medium-Term Culture of Primary Oral Squamous Cell Carcinoma in a Three- Dimensional Model: Effects on Cell Survival Following Topical 5-Fluororacile …

2012

Since the activity of several conventional anticancer drugs is restricted by resistance mechanisms and dose-limiting side-effects, the design of formulations for local application on malignant lesions seems to be an efficient and promising drug delivery approach. In this study, the effect of locally applied 5-FU on cell death was evaluated both in a SCC4/HEK001 model and in a newly proposed 3D outgrowth model of oral squamous cell carcinoma (OSCC). Initially, the optimal drug dose was established by delivery of solutions containing different amounts of 5-FU. The solution containing 1% (w/v) of 5-FU resulted effective in inducing cell death with complete eradication of cell colonies. Buccal …

DrugAntimetabolites AntineoplasticProgrammed cell deathCell Survivalmedia_common.quotation_subjectCellCell Culture TechniquesApoptosisCell CommunicationMatrix (biology)PharmacologyExcipientsDrug Delivery SystemsMicroscopy Electron TransmissionCell Line TumorDrug DiscoverymedicineHumansmedia_commonPharmacologyTUNEL assayDose-Response Relationship Drugbusiness.industryCancerBuccal administrationmedicine.diseasemedicine.anatomical_structureAcrylatesDrug deliveryCarcinoma Squamous CellMethacrylatesMouth NeoplasmsFluorouracilbusinessTabletsCurrent Pharmaceutical Design
researchProduct

A case of squamocellular uterine cervix carcinoma metastatic to the skin with enterocutaneous fistula.

2006

Metastases to the skin complicated by enterocutaneous fistula are a rare event in gynecological malignancies. We present the case of a 70-year-old woman with uterine cervix carcinoma metastatic to the skin and treated with surgery and radiotherapy. The last relapse to the skin was complicated by the formation of an enterocutaneous fistula. This low-output fistula was treated with surgery and adequate supportive care. The treatment of enterocutaneous fistulas may be either invasive (surgical resection, surgical repair with corrective procedures or with myocutaneous flaps, colonic and/or urinary diversion, endoscopic treatments with metallic stents) or conservative (skin care and local disin…

Enterocutaneous fistulaCancer Researchmedicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentFistulaAuthor Keywords: enterocutaneous fistulaUterine Cervical NeoplasmsOctreotideIntestinal Fistulamedicineskin metastaseMANAGEMENTHumansuterine cervix carcinoma KeyWords Plus: SQUAMOUS-CELL CARCINOMAAgedSurgical repairPerformance statusIleal Diseasesbusiness.industryUterine Cervix CarcinomaUrinary diversionGeneral Medicinemedicine.diseaseCANCERSurgeryRadiation therapyOncologyCarcinoma Squamous CellFemalebusinessmedicine.drug
researchProduct

Comparative Analysis of Cell Proliferation Ratio in Oral Lichen Planus, Epithelial Dysplasia and Oral Squamous Cell Carcinoma

2009

Made available in DSpace on 2013-08-12T18:47:57Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-11-01 Made available in DSpace on 2013-09-30T18:34:12Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-11-01 Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-20T14:04:33Z No. of bitstreams: 0 Made available in DSpace on 2014-05-20T14:04:33Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-11-01 Background: Although oral lichen planus has been classified by the World Health Organization (WHO) as a potentially malignant disorder, such classification is still the target of much controversy. Aim: To evaluate the cell proliferation rate in oral lic…

Epithelial dysplasiaPathologymedicine.medical_specialtyAgnorstomatognathic systemOral and maxillofacial pathologyepithelial dysplasiaCarcinomaMedicineHumansBasal cellskin and connective tissue diseasesGeneral DentistryCell Proliferationintegumentary systembusiness.industryCell growthMouth Mucosamedicine.disease:CIENCIAS MÉDICAS [UNESCO]oral squamous cell carcinomastomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASOral lichen planusimmunohistochemistryCarcinoma Squamous CellImmunohistochemistrySurgeryOral lichen planusMouth NeoplasmsbusinessLichen Planus Oral
researchProduct

Koinzidenz von Plattenepithelkarzinomen der Speiseröhre und Kopf-Hals-Karzinomen: Risiko und Früherkennung

2007

Patients suffering from head and neck cancer (HNC) have or will develop a second esophageal squamous cell cancer (ESCC) in 5 - 14 %. When a second esophageal neoplasm occurs in a HNC patient, the prognosis is generally determined by the ESCC, and unfortunately it is poor. Prospective clinical studies in Japan, Brazil, Taiwan, France and Germany have shown that screening or surveillance using Lugol chromoesophagoscopy enables early detection of second esophageal neoplasias. Such a surveillance results in a survival benefit for HNC patients. Vice versa, ESCC patients also have a risk of 9.3 - 11.4 % for a head and neck cancer. Periodic otolaryngeal examination and pharyngoscopy is recommended…

Esophageal Neoplasmmedicine.medical_specialtySquamous cell cancerbusiness.industryHead and neck cancerGastroenterologyEarly detectionmedicine.diseaseGastroenterologyUpper digestive tractdigestive system diseasesSurvival benefitField cancerisationOncologyPharyngoscopyInternal medicinemedicinebusinessZeitschrift für Gastroenterologie
researchProduct

Effects of fermented wheat germ extract on oral squamous cell carcinoma. An in vitro study

2020

Fermented Wheat Germ ExtractOral Squamous Cell Carcinoma
researchProduct